EMJ Podcast: Latest Developments in RET-driven lung cancer - European Medical Journal

EMJ Podcast: Latest Developments in RET-driven lung cancer

Bonus Episode

Latest Developments in RET-driven lung cancer

This podcast, supported by an educational grant from Eli Lilly, explores the latest developments in RET‑driven lung cancer that were presented at the American Society of Clinical Oncology’s (ASCO) 2021 virtual conference. Hear from two experts, Dr Maximilian Hochmair and Dr Fernando Lopez-Rios, as they discuss the importance of the RET gene, the latest safety and efficacy information, the role of testing, and future predictions within this landscape.

Spotify | Apple | AcastDownload MP3 (mp 33:46 mins)

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>